home / stock / sgiof / sgiof news

SGIOF News and Press, Shionogi & Co Ltd

Stock Information
Company Name: Shionogi & Co Ltd
Stock Symbol: SGIOF
Market: OTC
Menu
SGIOF SGIOF Quote SGIOF Short SGIOF News SGIOF Articles SGIOF Message Board
Get SGIOF Alerts

News, Short Squeeze, Breakout and More Instantly...
SGIOF - ViiV says early-stage data on VH184 for HIV could support twice-yearly dosing

2026-02-25 15:50:28 ET More on GSK, Pfizer Pfizer: A Risky 6.3% Yield For Income-Oriented Investors Q4 Healthcare Dividends: Johnson & Johnson Kept Outshining Pfizer (Rating Upgrades) Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround ...
SGIOF - Pfizer exits GSK majority-owned ViiV Healthcare; Shionogi raises stake

2026-01-20 13:30:02 ET More on Pfizer, GSK, etc. Pfizer: Rebound Has Just Started Pfizer: The Most Intriguing Value Play Of 2026 GSK plc (GSK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript RFK Jr. has reportedly removed four members of ...

SGIOF - Roche's Genentech launches DTC program amid Trump's MFN directive

2025-10-16 12:18:38 ET More on Roche Holding Roche's Giredestrant: A Ray Of Hope On A Cloudy Horizon? Roche Holding AG (RHHBY) Discusses On Pharma Day 2025 (Transcript) Roche Holding AG (RHHBY) Special Call - Slideshow Roche, Eli Lilly Alzheimer's blood diagn...

SGIOF - ViiV says its HIV PrEP therapy outperformed Gilead's lenacapavir in early-stage trial

2025-10-15 07:49:59 ET More on Pfizer, GSK, etc. GSK: Compelling Value, No Red Flags Ahead Of Earnings, Blenrep FDA Decision Soon Pfizer's Q3: The Catalyst For A Bullish Resurgence (Earnings Preview) GSK's Hidden Growth Engines Beyond HIV And Oncology Pfizer ...
SGIOF - Shionogi & Co., Ltd. (SGIOY) Q1 2025 Earnings Call Transcript

2025-07-29 08:35:31 ET Shionogi & Co., Ltd. (SGIOY) Q1 2025 Earnings Conference Call July 28, 2025 03:30 AM ET Company Participants John A. Keller - Senior Exec. Officer, SVP of R&D Supervisory Unit and Pharma. Tech. Research Div. & Director Masako Kudou ...

SGIOF - Shionogi & Co. reports Q1 results

2025-07-28 04:34:00 ET More on Shionogi & Co. ViiV expands license to produce generic Apretude in low-income countries Key deals this week: Sunoco, TaskUS, BP, DoorDash, Gold Fields and more Seeking Alpha’s Quant Rating on Shionogi & Co. Hi...

SGIOF - Shionogi to buy Japan Tobacco's Torii Pharma in a deal worth over $1B

2025-05-07 11:56:59 ET More on Japan Tobacco, Shionogi, etc. Japan Tobacco: Enjoy The Income While Waiting For Growth Japan Tobacco Inc. (JAPAY) Full Year 2024 Earnings Call Transcript Japan Tobacco Inc. (JAPAF) Q4 2024 Earnings Call Transcript FDA youth prev...
SGIOF - Democrats warn Trump about consequences of HIV prevention cuts

2025-03-21 14:14:13 ET More on Gilead Sciences, GSK, etc. Gilead: Growth Constraints Lead To Rating Downgrade Following 50% Rally Gilead Sciences, Inc. (GILD) Leerink Partners Global Healthcare Conference - (Transcript) Gilead Sciences, Inc. (GILD) TD Cowen 45th Annu...

SGIOF - ViiV releases promising phase 2 data on potential long-acting HIV drugs

2025-03-11 17:29:39 ET More on GSK GSK plc (GSK) TD Cowen 45th Annual Health Care Conference (Transcript) GSK's Strong Performance: Why I'm Upgrading To 'Strong Buy' GSK Reported Strong Earnings, So I Reiterate My Strong Buy GSK shares rise for seven consecut...

SGIOF - Shionogi targets JPY550B revenue through QOL focus and global expansion

2025-01-31 22:54:00 ET More on Shionogi & Co., Shionogi & Co., etc. Shionogi & Co., Ltd. (SGIOY) Q3 2024 Earnings Call Transcript Historical earnings data for Shionogi & Co. Dividend scorecard for Shionogi & Co. Financial information for S...
Next 10